publicações selecionadas
-
artigo académico
- Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Molecular Biology Reports. 2020
- Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature. Surgical Neurology International. 2013
- Suicide Attempts after Subthalamic Nucleus Stimulation for Parkinson’s Disease. European Neurology. 2010
-
artigo de revista
- Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?. International Journal of Molecular Sciences. 2020
- Serum lactate levels are associated with glioma malignancy grade. Clinical Neurology and Neurosurgery. 2019
- Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas.. Tumor Biology. 2018
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- Impact of TGF-ß1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumor Biology. 2015
- Immunoglobulin genes implicated in glioma risk.. Oncoimmunology. 2014
- Analysis of a synchronous gliosarcoma and meningioma with long survival : a case report and review of the literature. Surgical Neurology International. 2013
- Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation. Journal of Oncology. 2013
- Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiology Biomarkers & Prevention. 2011
- Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study. Oncology Reports. 2010
-
documento